500 Mg Amifostine For Injection USP

Get a Price/Quote

MOQ : 1 Vial

500 Mg Amifostine For Injection USP Specification

Salt Composition
Amifostine 500 mg

Dosage Form
For Injection

Indication
Cytoprotective agent, reduction of nephrotoxicity associated with cisplatin chemotherapy, reduction of xerostomia from radiation therapy

Feature
Sterile, lyophilized, single-use vial

Ingredients
Amifostine USP, excipients

Application

Physical Color/Texture
White or almost white lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months

Contraindications
Hypersensitivity to active ingredient or excipients, hypotension

Intended Patient Population
Adults undergoing chemotherapy or head and neck radiotherapy

Packaging Type
Glass vial with flip-off cap

Usage in Pediatrics
Safety and efficacy in pediatrics not established

Vial Size
500 mg per vial

Prescription Status
Prescription only

Reconstitution Solvent
Sterile water for injection

Route of Administration
Intravenous (IV) infusion after dilution

Manufacturing Standard
USP (United States Pharmacopeia) grade

About 500 Mg Amifostine For Injection USP

Experience phenomenal promotion and instant savings with our Sterling 500 Mg Amifostine For Injection USP. This enviable cytoprotective agent, manufactured to USP standards, ensures optimal efficacy for adults undergoing chemotherapy or head and neck radiotherapy. Each glass vial contains a 500 mg dose, presented as a sterile, lyophilized powder-ready for reconstitution with sterile water for injection. Offered at competitive pricing, this product helps reduce nephrotoxicity associated with cisplatin and mitigates xerostomia from radiation. Prescription is required. Strict contraindications apply. Shelf life: 24 months. Stock ready for prompt supply.

Comprehensive Oncology Application

500 Mg Amifostine For Injection USP serves as an adjunct in oncology, specifically for adults undergoing chemotherapy or head and neck radiotherapy. Designed for intravenous (IV) infusion after reconstitution, its enviable cytoprotective properties help reduce nephrotoxicity from cisplatin and prevent xerostomia caused by radiation. The site of application is strictly intravenous, making it suitable for hospital and clinical settings. This sterling pharmaceutical solution offers significant patient benefit in cancer care protocols.

Packaging, Sample, and Domestic Market Information

The product is supplied in a glass vial with a secure flip-off cap, containing white or nearly white lyophilized powder for instant reconstitution. Our domestic market coverage ensures stock ready availability and express shipping across India. Distributors benefit from robust sample policies designed for ease of assessment. The main domestic market is India, with exceptional logistics ensuring prompt delivery and steady stock for healthcare providers and traders alike.

FAQ's of 500 Mg Amifostine For Injection USP:

Q: How should 500 Mg Amifostine For Injection USP be administered?

A: This product is intended for intravenous (IV) infusion after dilution with sterile water, under strict medical supervision and prescription.

Q: What are the main benefits of using Amifostine 500 mg in cancer treatment?

A: Amifostine 500 mg is a cytoprotective agent that greatly reduces the risk of nephrotoxicity from cisplatin chemotherapy and lessens xerostomia in patients undergoing head and neck radiotherapy.

Q: When is Amifostine 500 mg contraindicated?

A: It should not be used in patients with known hypersensitivity to amifostine or any of its excipients, or in those with hypotension.

Q: Where can I purchase stock ready 500 Mg Amifostine vials?

A: The product is distributed, exported, and supplied by certified traders in India, ensuring express shipping and ready availability in the domestic market.